A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer

被引：0
|
作者：
Heather Wakelee
George A. Fisher
机构：
[1] Stanford Clinical Cancer Center,
来源：
Investigational New Drugs | 2005年 / 23卷
关键词：
amifostine; irinotecan; phase I; colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：241 / 242
页数：1
相关论文
共 50 条
  • [41] A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer
    Sabharwal, A.
    Corrie, P.
    Seebaran, A.
    Anderson, D.
    Carmichael, J.
    Mortimer, P.
    Margison, G. P.
    Watson, A.
    Middleton, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following i.v. infusion of [14C]CPT-11 in cancer patients
    Slatter, JG
    Schaaf, LJ
    Sams, JP
    Feenstra, KL
    Johnson, MG
    Bombardt, PA
    Cathcart, KS
    Verburg, MT
    Pearson, LK
    Compton, LD
    Miller, LL
    Baker, DS
    Pesheck, CV
    Lord, RS
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (04) : 423 - 433
  • [43] A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer
    Sabharwal, A.
    Corrie, P. G.
    Midgley, R. S.
    Palmer, C.
    Brady, J.
    Mortimer, P.
    Watson, A. J.
    Margison, G. P.
    Middleton, M. R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (05) : 829 - 835
  • [44] Phase I/II study of combination therapy with S-1 and CPT-11 for metastatic colorectal cancer
    Nakafusa, Yuji
    Tanaka, Masayuki
    Ohtsuka, Takao
    Miyoshi, Atsushi
    Kohya, Naohiko
    Kitajima, Yoshihiko
    Sato, Seiji
    Mochinaga, Sakiko
    Dohi, Sawako
    Miyazaki, Kohji
    MOLECULAR MEDICINE REPORTS, 2008, 1 (06) : 925 - 930
  • [45] Irinotecan (CPT-11) in combination with raltitrexed (TX) in patients with previously untreated, advanced colorectal cancer (ACC) patients.: Preliminary results of a phase I/II trial.
    Losa, F
    Manzano, H
    Vicente, P
    Rifa, J
    Ocaña, J
    Balcells, M
    Mediavilla, D
    Heras, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 288S - 288S
  • [46] Irinotecan (CPT-11)-based chemotherapy as induction treatment for advanced colorectal cancer
    Quintela-Fandino, M
    Gravalos, C
    Gonzalez, E
    Garcia-Velasco, A
    Cortés-Funes, H
    ANTI-CANCER DRUGS, 2005, 16 (01) : 31 - 38
  • [47] Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancer
    J. Cassinello
    P. López-Alvarez
    A. Martínez-Guisado
    M. Valladares
    G. Huidobro
    R. López
    U. Bohn
    I. Sevilla
    P. Ballesteros
    M. Jorge
    R. Pérez-Carrión
    J. L. Fernández
    J. Dorta
    Medical Oncology, 2003, 20 : 37 - 43
  • [48] Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancer
    Cassinello, J
    López-Alvarez, P
    Martínez-Guisado, A
    Valladares, M
    Huidobro, G
    López, R
    Bohn, U
    Sevilla, I
    Ballesteros, P
    Jorge, M
    Pérez-Carrión, R
    Fernández, JL
    Dorta, J
    MEDICAL ONCOLOGY, 2003, 20 (01) : 37 - 43
  • [49] A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma
    Sanz-Altamira, PM
    O'Reilly, E
    Stuart, KE
    Raeburn, L
    Steger, C
    Kemeny, NE
    Saltz, LB
    ANNALS OF ONCOLOGY, 2001, 12 (04) : 501 - 504
  • [50] Effect of Irinotecan (CPT-11) on fatty acid status in rats with colorectal cancer
    Krishnamurthi, Veena
    Pawlowicz, Megan
    Xue, Hongyu
    Baracos, Vickie
    Clandinin, M. Thomas
    Mazurak, Vera C.
    FASEB JOURNAL, 2008, 22
12345